Emerging Lp(a)-Lowering therapies: Is muvalaplin a potential breakthrough?

被引：1
|
作者：
Afzal, Zeeshan [1 ,4 ]
Hira, Sara [2 ]
Cao, Huili [3 ]
机构：
[1] Shanxi Med Univ, Dept Internal Med, Taiyuan, Peoples R China
[2] FMH Coll Med & Dent, Lahore, Pakistan
[3] Shanxi Med Univ, Dept Cardiol, Hosp 2, Taiyuan, Shanxi, Peoples R China
[4] Shanxi Med Univ Shanxi, Taiyuan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION | 2024年 / 21卷
关键词：
LIPOPROTEIN(A);
D O I：
10.1016/j.ijcrp.2024.200262
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Oral Muvalaplin for Lowering of Lipoprotein(a) A Randomized Clinical Trial
    Nicholls, Stephen J.
    Ni, Wei
    Rhodes, Grace M.
    Nissen, Steven E.
    Navar, Ann Marie
    Michael, Laura F.
    Haupt, Axel
    Krege, John H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (03): : 222 - 231
  • [2] POTENTIAL FUNDING SOURCES FOR BREAKTHROUGH THERAPIES
    Hanna, E.
    Remuzat, C.
    Auquier, P.
    Dussart, C.
    Toumi, M.
    VALUE IN HEALTH, 2017, 20 (09) : A659 - A659
  • [3] Update on emerging urate-lowering therapies
    Chohan, Saima
    Becker, Michael A.
    CURRENT OPINION IN RHEUMATOLOGY, 2009, 21 (02) : 143 - 149
  • [4] Sulfonamides as potential Lp(a) lowering agents.
    Sexton, KE
    Lee, HT
    Pontrello, JK
    Roth, BD
    Spahr, MA
    Ramharack, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U978 - U978
  • [5] Potential of muvalaplin as a lipoprotein(a) inhibitor
    Hooper, Amanda J.
    Fernando, P. Mihika S.
    Burnett, John R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (01) : 5 - 7
  • [6] Emerging glucose-lowering therapies: a guide for cardiologists
    Gulsin, Gaurav S.
    Graham-Brown, Mathew P. M.
    Davies, Melanie J.
    Mccann, Gerry P.
    HEART, 2020, 106 (01) : 18 - 23
  • [7] Emerging Lipid-Lowering Therapies in Secondary Prevention
    Dhruv Mahtta
    Salim S. Virani
    Anthony A. Bavry
    Current Cardiovascular Risk Reports, 2019, 13
  • [8] Expert opinion on emerging urate-lowering therapies
    Stamp, Lisa K.
    Merriman, Tony R.
    Singh, Jasvinder A.
    EXPERT OPINION ON EMERGING DRUGS, 2018, 23 (03) : 201 - 209
  • [9] Emerging Lipid-Lowering Therapies in Secondary Prevention
    Mahtta, Dhruv
    Virani, Salim S.
    Bavry, Anthony A.
    CURRENT CARDIOVASCULAR RISK REPORTS, 2019, 13 (06)
  • [10] Emerging and potential therapies for osteoporosis
    Grey, A
    Reid, IR
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (03) : 265 - 278
12345